SCHEMBL7423751

SCHEMBL7423751

CC=CC(Cl)c1ccc(F)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.35
TDO2 P48775 2/20 0.35
ACHE P22303 1/20 0.33
AOC3 Q16853 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
NFE2L2 Q16236 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568105 0.77 TSHR (0.46) MEN1KMT2AATM
SCHEMBL6981619 0.77 IDO1 (0.38) IDO1TDO2ACHEAOC3MEN1
SCHEMBL8773918 0.74 MEN1 (0.52) IDO1TDO2ACHEAOC3MEN1
SCHEMBL1028130 0.73 IDO1 (0.38) IDO1TDO2HDAC3HDAC4HDAC1
Ammonia Solution, Strong SCHEMBL27969947 0.71 IDO1 (0.37) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL11001158 0.71 MAPT (0.45) ACHEMEN1KMT2AALDH1A1GAA
SCHEMBL930683 0.69 IDO1 (0.42) IDO1TDO2ACHEAOC3HDAC3
SCHEMBL6959704 0.68 MEN1 (0.64) AOC3MEN1KMT2AATMSLC6A2
SCHEMBL424538 0.68 IDO1 (0.46) IDO1TDO2ACHEAOC3HDAC3
SCHEMBL6903910 0.68 TSHR (0.50) IDO1TDO2ACHEAOC3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1370176-A Subsstituted heterocycle fused gamma-carbolines BRISTOL MYERS SQUIBB CO (US) 2002-09-18 CN disclosed
EP-1192165-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES Bristol-Myers Squibb Pharma Company (US) 2002-04-03 EP disclosed
WO-2000077010-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES DU PONT PHARMACEUTICALS COMPANY (US) 2000-12-21 WO disclosed